It is a pharma private limited company based in Coimbatore, Tamil Nadu, India, established in 2022.
2022 | Coimbatore, Tamil Nadu, India | ActiveGlenmore India Pharmaceutical Private Limited, a active private limited company, was established on 25 July 2022 in Coimbatore, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909TZ2022PTC039549. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Kanagaraj Sivaraman (Director), Mathappan Murugesan (Director), Radhakrishnan Kamala Kannan (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sf 256/2, Site No21, Dharshan Avenue, Nallampalayam, Coimbatore, Tamil Nadu, 641006.
U51909TZ2022PTC039549
039549
25 July 2022
₹1.50 M
₹1.50 M
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Glenmore India Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kanagaraj Sivaraman | Director | 25 Jul 2022 | Current |
| Mathappan Murugesan | Director | 25 Jul 2022 | Current |
| Radhakrishnan Kamala Kannan | Director | 25 Jul 2022 | Current |
| Rajasekaran | Additional Director | 23 May 2025 | Current |
| Srinivasan Boopathi | Additional Director | 23 May 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Glenmore India Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Glenmore India Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Glenmore India Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glenmore India Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenmore India Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Glenmore India Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Rajasekaran was appointed as a Additional Director was appointed as a Additional Director on 23 May 2025 & has been associated with this company since 7 months 3 days . was documented.
Progress on Srinivasan Boopathi was appointed as a Additional Director was appointed as a Additional Director on 23 May 2025 & has been associated with this company since 7 months 3 days . was documented.
Glenmore India Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Coimbatore. was recorded as a recent event.
Progress on Kanagaraj Sivaraman was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 3 years 5 months . was documented.
Progress on Mathappan Murugesan was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 3 years 5 months . was documented.
The CIN of Glenmore India Pharmaceutical Private Limited is U51909TZ2022PTC039549.
Glenmore India Pharmaceutical Private Limited is headquartered at Sf 256/2, Site No21, Dharshan Avenue, Nallampalayam, Coimbatore, Tamil Nadu, 641006.
Glenmore India Pharmaceutical Private Limited was incorporated on 25 July 2022.
The current directors of Glenmore India Pharmaceutical Private Limited are
The primary industry of Glenmore India Pharmaceutical Private Limited is Pharma.
Glenmore India Pharmaceutical Private Limited is unlisted.
The authorized capital of Glenmore India Pharmaceutical Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX